Minims fluorescein sodium 1% eye drops 0.5ml unit dose

País: Reino Unido

Língua: inglês

Origem: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredientes ativos:

Fluorescein sodium

Disponível em:

Bausch & Lomb UK Ltd

Código ATC:

S01JA01

DCI (Denominação Comum Internacional):

Fluorescein sodium

Dosagem:

10mg/1ml

Forma farmacêutica:

Eye drops

Via de administração:

Ocular

Classe:

No Controlled Drug Status

Tipo de prescrição:

Valid as a prescribable product

Resumo do produto:

BNF: 11080200; GTIN: 5027519000807

Características técnicas

OBJECT 1
MINIMS FLUORESCEIN SODIUM 1% W/V, EYE DROPS
SOLUTION
Summary of Product Characteristics Updated 28-Jul-2016 | Bausch & Lomb
U.K Limited
1. Name of the medicinal product
Minims Fluorescein Sodium 1%
2. Qualitative and quantitative composition
1% w/v solution of Fluorescein Sodium BP.
3. Pharmaceutical form
Single-use, sterile eye drops.
4. Clinical particulars
4.1 Therapeutic indications
As a diagnostic stain.
Fluorescein does not stain a normal cornea but conjunctival abrasions
are stained yellow or orange,
corneal abrasions or ulcers are stained a bright green and foreign
bodies are surrounded by a green ring.
Fluorescein can be used in diagnostic examinations including Goldmann
tonometry and in the fitting of
hard contact lenses.
4.2 Posology and method of administration
Adults, Children and the Elderly
Instil dropwise into the eye.
Sufficient solution should be applied to stain the damaged areas.
Excess may be washed away with sterile
saline solution.
4.3 Contraindications
Not to be used with soft contact lenses.
4.4 Special warnings and precautions for use
Special care should be taken to avoid microbial contamination.
_Pseudomonas aeruginosa_ grows well in
fluorescein solutions, therefore, a single dose solution is preferred.
Each Minims unit should be discarded
after a single use.
4.5 Interaction with other medicinal products and other forms of
interaction
None known.
4.6 Pregnancy and lactation
Safety for use in pregnancy and lactation has not been established,
therefore use only when considered
essential by the physician.
4.7 Effects on ability to drive and use machines
May cause transient blurring of vision on instillation. Warn patients
not to drive or operate hazardous
machinery until vision is clear.
4.8 Undesirable effects
ADRs are very rare(<1/10,000),including isolated reports.
Symptoms of allergic-type reactions and anaphylaxis have been reported
following topical ophthalmic
administration of Fluorescein sodium and may manifest as:
Eye disorders: allergic conjunctivitis, peri-orbital oedem